Sym004-induced EGFR elimination is associated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models
Stephen T. Keir(Duke University), Darell D. Bigner(Duke Medical Center)
Cited by 7
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k
Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy
|Nature Medicine|2012|756
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis
|The Lancet Oncology|2013|404